Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

lipid nanocapsules transacylated with chitosan/anti-EGFR siRNA complexes

Based on

1 Articles
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

chitosan- transacylated lipid nanocapsules

chitosan-transacylated LNC
Type Nano Material
Formula
Role raw materials
2

anti-epidermal growth factor receptor small interfering ribonucleic acid

small interfering ribonucleic acid anti-EGFR siRNA siRNA
Type Biomolecule
Formula
Role graft

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
Zeta potential

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
fluorescence spectroscopy

More information available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
epidermal growth factor receptors of U87MG glioblastoma cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  1. OZDyHRlCtMeWtEdcmTTmq
Product

lipid nanocapsules transacylated with chitosan/anti-EGFR siRNA complexes

Size: 92.9 - 94.5 nm

Medium: water

Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  1. GB9UUnSLKspOhvx9eJexb
Product

lipid nanocapsules transacylated with chitosan/anti-EGFR siRNA complexes

Size: 91.0 - 98.8 nm

Medium: water

Support: none

Method 3

Type: Physical formation
Source:
Starting materials
  1. MzPVQHOQZKFziNp3tw0cc
Product

lipid nanocapsules transacylated with chitosan/anti-EGFR siRNA complexes

Size: ~ 95.5 nm

Medium/Support: none

Method 4

Type: Physical formation
Source:
Starting materials
  1. NIAn9lAKH95KiJOjoVekY
Product

lipid nanocapsules transacylated with chitosan/anti-EGFR siRNA complexes

Size: ~ 96.4 nm

Medium/Support: none

Method 5

Type: Physical formation
Source:
Starting materials
  1. CuZ4I3C2MeEuR9l39QsEG
Product

lipid nanocapsules transacylated with chitosan/anti-EGFR siRNA complexes

Size: ~ 93.7 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial